Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- GSK announced that its Jideytro (zidesamtinib) achieved a 94% objective response rate in TKI-naïve ROS1-positive non-small cell lung cancer patients in the registrational phase I/II ARROS-1 trial, with no placebo comparator.
- AstraZeneca’s breast-cancer pill trial failure could cut several billion dollars from the drug’s potential sales, according to analysts. 

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - GSK announced that its Jideytro (zidesamtinib) achieved a 94% objective response rate in TKI-na&iuml;ve ROS1-positive non-small cell lung cancer patients in the registrational phase I/II ARROS-1 trial, with no placebo comparator. - AstraZeneca&rsquo;s breast-cancer pill trial failure could cut several billion dollars from the drug&rsquo;s potential sales, according to analysts.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

GSK Jumps, Astrazeneca Up

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ca9075a9-ee6a-4f5d-b088-b4c5008b9a0e/transcript

Bloomberg’s Nathan Hager focuses on three stocks for the week ahead. They include: Lennar, Salesforce, and Take-Two.

Nathan previews what to expect from these companies in the week ahead with Avalon Pernell, Bloomberg Equities Reporter.

Bloomberg&rsquo;s Nathan Hager focuses on three stocks for the week ahead. They include: Lennar, Salesforce, and Take-Two. Nathan previews what to expect from these companies in the week ahead with Avalon Pernell, Bloomberg Equities Reporter.

Week Ahead: Lennar, Salesforce, and Take-Two 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9d5153cf-f806-4807-9425-b4c2013c9355/transcript

On this episode of Stock Movers, we take a look at some of the week's biggest gainers and decliners:

- Shares of Skyworks (SWKS) surged after CEO Philip Brace updated investors about the status of a key merger. The stock gained 26%, the best five-day session streak since a stretch in February 2009.

- Lululemon's (LULU) turnaround won't be a quick or easy fix as the company cedes market share to rivals and suffers deepening sales declines, according to BMO Capital Markets. BMO initiated coverage of the stock with an underperform rating and a $70 price target, assuming a roughly 29% decline from where the shares closed on Friday. Analysts say the company's "irrelevance with the consumer is showing up in the numbers" and that Lululemon will need to cut prices or liquidate merchandise to reinvigorate demand, which will also pressure margins. During trading on Friday, share rose to just under $100 per share at the close in New York. While the average price target of about $100 is near where shares traded at Friday’s close, the stock has slumped 52% this year and is down more than 80% from a December 2023 record.

- Cooper (COO) led the decliners in health care and lowered its full-year-outlook. On Thursday, it saw its shares tumble as much as 20%, the most intraday since 2008.

On this episode of Stock Movers, we take a look at some of the week's biggest gainers and decliners:
- Shares of Skyworks (SWKS) surged after CEO Philip Brace updated investors about the status of a key merger. The stock gained 26%, the best five-day session streak since a stretch in February 2009.
- Lululemon's (LULU) turnaround won't be a quick or easy fix as the company cedes market share to rivals and suffers deepening sales declines, according to BMO Capital Markets. BMO initiated coverage of the stock with an underperform rating and a $70 price target, assuming a roughly 29% decline from where the shares closed on Friday. Analysts say the company's "irrelevance with the consumer is showing up in the numbers" and that Lululemon will need to cut prices or liquidate merchandise to reinvigorate demand, which will also pressure margins. During trading on Friday, share rose to just under $100 per share at the close in New York. While the average price target of about $100 is near where shares traded at Friday&rsquo;s close, the stock has slumped 52% this year and is down more than 80% from a December 2023 record.
- Cooper (COO) led the decliners in health care and lowered its full-year-outlook. On Thursday, it saw its shares tumble as much as 20%, the most intraday since 2008.

Weekly Roundup: Skyworks Surges, Lululemon Falls, Cooper Drops

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/516de8b2-4161-4ad3-91b3-b4c20177dc3d/transcript

Today's biggest winners and losers in the stock market, a look at the notable movers:

On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Carol Massar and Tim Stenovec. 

- HP Enterprise (HPE) shares rallied on Friday, with the company on track for a record close as it extends recent strength. Shares have risen more than 150% this year, supported by strong AI-related demand for its servers.

- Dell's (DELL) shares jumped as much as 12%, hitting a record high after RBC Capital Markets started coverage on the company with an outperform rating and $640 price target, with the firm citing strong AI infrastructure demand. 

- Oracle (ORCL) delivered quarterly cloud computing revenue that exceeded Wall Street’s expectations, though the company’s gross margins narrowed. The company saw its shares rally in extended trading immediately after earnings on Thursday. On Friday, shares were higher early before turning lower.

Today's biggest winners and losers in the stock market, a look at the notable movers:
On this episode of Stock Movers:
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Carol Massar and Tim Stenovec.&nbsp;
- HP Enterprise (HPE) shares rallied on Friday, with the company on track for a record close as it extends recent strength. Shares have risen more than 150% this year, supported by strong AI-related demand for its servers.
- Dell's (DELL) shares jumped as much as 12%, hitting a record high after RBC Capital Markets started coverage on the company with an outperform rating and $640 price target, with the firm citing strong AI infrastructure demand.&nbsp;
- Oracle (ORCL) delivered quarterly cloud computing revenue that exceeded Wall Street&rsquo;s expectations, though the company&rsquo;s gross margins narrowed. The company saw its shares rally in extended trading immediately after earnings on Thursday. On Friday, shares were higher early before turning lower.

Closing Bell: HPE Rallies, Dell Gains, Oracle Slips 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/120ac223-9b6a-47a8-9f61-b4c2015881c5/transcript

GSK Jumps, Astrazeneca Up

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips